Health Care: Drugs

Puma Biotechnology Inc (PBYI: NYSE)

$216 -1.38 | -0.63%
03/27/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 217.38
52 Week High 279.37
52 Week Low 53.63
Avg. Daily Vol. (Mil) 0.29
Beta (3 year) -2.09
Share Related Items
Mkt Cap (Mil) 6,938.60
Shares Out (Mil) 31.92
Float (Mil) 20.23
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 59.28
Price/Cash Flow -49.10
Per Share Data
Earnings -4.73
Sales 0.00
Book Value 3.67
Cash Flow -4.43
Business Summary
Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.
General Information
10880 Wilshire Boulevard
Suite 2150
Los Angeles, CA 90024
www.pumabiotechnology.com
Industry : Drugs
Sector: Health Care
Employees: 120
CEO: Alan H. Auerbach
Short Interest
Current Month (Mil) 2.66
Previous Month (Mil) 2.71
Short Interest Ratio (Days) 8.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -87.20
Return on Investments -121.30
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PBYI

Latest PBYI Headlines from TheStreet

More Financial News for PBYI

Press Releases for PBYI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter